A Combined Exercise Programme Involving Strengthening, Flexibility and Aerobic Exercise for Lower Back Pain: a Randomised-controlled Study

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This randomised controlled trial will evaluate the effectiveness of different exercise modalities for individuals with low back pain. Participants will be allocated to one of three groups: a control arm (usual exercise), a running-based intervention, or a swimming/cycling-based intervention. Outcomes related to pain and function will be measured at baseline, 8 weeks, and 12 months.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 45
Healthy Volunteers: t
View:

• Aged 18-45 years

• Participant is willing and able to give informed consent for participation in the study

• Suffering from chronic NSLBP (more than 3 months, localised below the costal margin and above the gluteal folds)

• Suffers from pain or functional limitations as a result of their LBP (minimum VAS (back) score of 3/10 or ODI score of at least 5/50 or RMD score of at least 5/24 (note, unlike ODI, RMD does not describe specific cuts offs for different levels of disability)

• Able to exercise

Locations
Other Locations
United Kingdom
University of Nottingham, Queen's Medical Centre
RECRUITING
Nottingham
Time Frame
Start Date: 2025-04-01
Estimated Completion Date: 2026-09-30
Participants
Target number of participants: 88
Treatments
No_intervention: Control Group
Participants continue with their usual exercise regime.
Experimental: Runner Group
Particpants follow an 8 week intervention including aerobic elements (running), a schedule of gradually intensitfing strengthening exercises and flexibility exercises.
Experimental: Swim/Cycle group
Particpants follow an 8 week intervention including aerobic elements (swim/cycle), a schedule of gradually intensitfing strengthening exercises and flexibility exercises.
Related Therapeutic Areas
Sponsors
Leads: University of Nottingham

This content was sourced from clinicaltrials.gov